Novel Drug Shows Significant Promise in Treating Severe Stroke Patients (February 6, 2012)

Senator Kirk’s Stroke Shines A Light On The Need For a Cure (January 31, 2012)

Traumatic Brain Injury Study Begins Recruiting Patients (November 14, 2011)

Two Additional Hospitals Begin Recruiting for Stroke Study (November 14, 2011)

Remedy Pharmaceuticals Announces Traumatic Brain Injury Drug Study (July 1, 2011)

Massachusetts General Hospital Begins Recruiting for Stroke Study (June 26, 2011)

First Patient Treated in Severe Stroke Study (May 31, 2011)

Severe Stroke Clinical Study To Begin Patient Recruitment (April 23, 2011)

Remedy is Awarded Another Key Patent by the USPTO (January 18, 2011)

Remedy Pharmaceuticals Receives Therapeutic Discovery Grants totaling $733,437 (November 2, 2010)

Remedy Pharmaceuticals Successfully Completes Phase 1 Study (September 25, 2010)

Study Published in Stroke Offers Promise to Severe Stroke Victims (March 31, 2010)

Remedy Pharmaceuticals Begins Phase 1 Safety Study (January 25, 2010)

ING Pharma and BRCC Invest in Remedy Pharmaceuticals (January 10, 2010)

Study Published in Journal of Neurotrauma Offers Promise to Brain Injury Victims (December 28, 2009)

Remedy Pharmaceuticals Files Investigational New Drug Application with FDA (December 23, 2009)

Study Published in Stroke Offers Promise to Ischemic Stroke Victims (February 27, 2009)

Drug Shown To Be Effective In Treating Stroke (February 23, 2009)

Remedy Pharmaceuticals Finalizes Formulation Of Lead Drug (July 18, 2008)

U.S. Patent Awarded For Stroke And Traumatic Brain Injury (October 23, 2007)

Study Published in Stroke Shows Drug To Be Effective (September 23, 2007)